Crossmark

Intermittent high-fat diet: atherosclerosis progression by neutrophil reprogramming

Published Online: 2024-11-07

Authors

Herrero-Cervera, Andrea

Chevre, Raphael

Soehnlein, Oliver https://orcid.org/0000-0002-7854-0694
License Information

Text and Data Mining valid from 2024-11-07

Version of Record valid from 2024-11-07
More Information

Article History

Received: 6 October 2024

Revised: 18 October 2024

Accepted: 21 October 2024

First Online: 7 November 2024

Competing interests

: O.S. is the advisor for ResoTher, Roche, and Novo Nordisk and receives funding from Novo Nordisk to study chronopharmacological and histone-neutralizing strategies in atherosclerosis.

Document is current